285 related articles for article (PubMed ID: 30548962)
1. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
[TBL] [Abstract][Full Text] [Related]
2. MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.
Bollwein C; Gonҫalves JPL; Utpatel K; Weichert W; Schwamborn K
Molecules; 2022 May; 27(11):. PubMed ID: 35684402
[TBL] [Abstract][Full Text] [Related]
3. Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.
Kriegsmann M; Casadonte R; Kriegsmann J; Dienemann H; Schirmacher P; Hendrik Kobarg J; Schwamborn K; Stenzinger A; Warth A; Weichert W
Mol Cell Proteomics; 2016 Oct; 15(10):3081-3089. PubMed ID: 27473201
[TBL] [Abstract][Full Text] [Related]
4. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
[TBL] [Abstract][Full Text] [Related]
5. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.
Djidja MC; Claude E; Snel MF; Scriven P; Francese S; Carolan V; Clench MR
J Proteome Res; 2009 Oct; 8(10):4876-84. PubMed ID: 19673544
[TBL] [Abstract][Full Text] [Related]
6. Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin-fixed paraffin-embedded tissues.
Casadonte R; Kriegsmann M; Zweynert F; Friedrich K; Baretton G; Otto M; Deininger SO; Paape R; Belau E; Suckau D; Aust D; Pilarsky C; Kriegsmann J
Proteomics; 2014 Apr; 14(7-8):956-64. PubMed ID: 24482424
[TBL] [Abstract][Full Text] [Related]
7. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
8. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT
PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793
[TBL] [Abstract][Full Text] [Related]
9. A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.
Boskamp T; Lachmund D; Oetjen J; Cordero Hernandez Y; Trede D; Maass P; Casadonte R; Kriegsmann J; Warth A; Dienemann H; Weichert W; Kriegsmann M
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):916-926. PubMed ID: 27836618
[TBL] [Abstract][Full Text] [Related]
10. Site-to-Site Reproducibility and Spatial Resolution in MALDI-MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples.
Ly A; Longuespée R; Casadonte R; Wandernoth P; Schwamborn K; Bollwein C; Marsching C; Kriegsmann K; Hopf C; Weichert W; Kriegsmann J; Schirmacher P; Kriegsmann M; Deininger SO
Proteomics Clin Appl; 2019 Jan; 13(1):e1800029. PubMed ID: 30408343
[TBL] [Abstract][Full Text] [Related]
11. Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma.
Kazdal D; Longuespée R; Dietz S; Casadonte R; Schwamborn K; Volckmar AL; Kriegsmann J; Kriegsmann K; Fresnais M; Stenzinger A; Sültmann H; Warth A; Kriegsmann M
Proteomics Clin Appl; 2019 Jan; 13(1):e1800034. PubMed ID: 30216696
[TBL] [Abstract][Full Text] [Related]
12. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
13. MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.
Gonçalves JPL; Bollwein C; Schlitter AM; Kriegsmann M; Jacob A; Weichert W; Schwamborn K
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956764
[TBL] [Abstract][Full Text] [Related]
14. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
[TBL] [Abstract][Full Text] [Related]
15. Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer.
Cordero Hernandez Y; Boskamp T; Casadonte R; Hauberg-Lotte L; Oetjen J; Lachmund D; Peter A; Trede D; Kriegsmann K; Kriegsmann M; Kriegsmann J; Maass P
Proteomics Clin Appl; 2019 Jan; 13(1):e1700168. PubMed ID: 30520240
[TBL] [Abstract][Full Text] [Related]
16. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
17. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.
He M; Liu Z; Lin Y; Wan J; Li J; Xu K; Wang Y; Jin Z; Tian J; Xue H
Eur J Radiol; 2019 Aug; 117():102-111. PubMed ID: 31307634
[TBL] [Abstract][Full Text] [Related]
19. How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry?
Buck A; Balluff B; Voss A; Langer R; Zitzelsberger H; Aichler M; Walch A
Anal Chem; 2016 May; 88(10):5281-9. PubMed ID: 27065343
[TBL] [Abstract][Full Text] [Related]
20. MALDI Imaging for Proteomic Painting of Heterogeneous Tissue Structures.
Kriegsmann J; Kriegsmann M; Kriegsmann K; Longuespée R; Deininger SO; Casadonte R
Proteomics Clin Appl; 2019 Jan; 13(1):e1800045. PubMed ID: 30471204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
